Centiva Capital’s Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share CLBR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-96,981
Closed -$29.1K 2192
2024
Q2
$29.1K Hold
96,981
﹤0.01% 1955
2024
Q1
$44.6K Buy
+96,981
New +$42.2K ﹤0.01% 1655

Other funds holding CLBR.WS

Centiva Capital's CLBR.WS Position: Q3 2024 in Review

Centiva Capital sold out of Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (CLBR.WS) in Q3 2024, closing a stake of 96,981 shares — an estimated $29.1K sold.

Centiva Capital first reported a position in CLBR.WS in Q1 2024 and held it in 2 quarters. The position peaked at $44.6K in Q1 2024. 24 funds tracked by Wall St. Rank hold CLBR.WS as of Q3 2024.

  • Centiva Capital reported no remaining Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 96,981 Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q3 2024, an estimated $29.1K.
  • Centiva Capital first reported a position in Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q1 2024 and held it in 2 quarters.
  • Centiva Capital's Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $44.6K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.